Prognia
Drug Database
🇺🇸US · FDA ApprovedPrescriptionBLA208471-002

ADLYXIN(LIXISENATIDE)

Manufacturer: SANOFI-AVENTIS US

FDA Approval: 27/07/2016

Route: SUBCUTANEOUS · SOLUTION

Active Ingredients

LIXISENATIDE 0.3MG/3ML (0.1MG/ML)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ADLYXIN — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.